Tamiflu capsule 75mg

Ország: Malajzia

Nyelv: angol

Forrás: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktív összetevők:

OSELTAMIVIR PHOSPHATE

Beszerezhető a:

ROCHE (MALAYSIA) SDN. BHD.

INN (nemzetközi neve):

OSELTAMIVIR PHOSPHATE

db csomag:

10Capsule Capsules

Gyártó:

CENEXI SAS

Betegtájékoztató

TAMIFLU
®
CAPSULES
_Oseltamivir 75 mg _
1
_ _
_ _
_Consumer Medication Information Leaflet (RiMUP) _
WHAT IS IN THIS LEAFLET
1.
What Tamiflu is used for
2.
How Tamiflu works
3.
Before you use Tamiflu
4.
How to use Tamiflu
5.
While you are using it
6.
Side effects
7.
Storage and disposal of Tamiflu
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT TAMIFLU IS USED FOR
Tamiflu is used for the treatment of
influenza in children 6 to 12 months
of age during pandemic influenza
outbreak, for treatment of influenza
in adults and children age 1 year
and above. Tamiflu is also indicated
for
post
exposure
prevention
in
adults and children age 1 year and
above
following
contact
with
clinically diagnosed influenza case
when influenza virus is circulating
in the community.
HOW TAMIFLU WORKS
Tamiflu contains oseltamivir which
belongs
to
a
group
of
medicines
named
neuraminidase
inhibitors.
These
medicines
prevent
the
influenza
virus
from
spreading
inside the body. They help to ease or
prevent
the
symptoms
of
the
influenza virus infection.
Influenza, usually called flu, is an
infection
caused
by
a
virus.
The
signs of flu often include a sudden
fever
(more
than
37.8°C),
cough,
runny
or
stuffy
nose,
headaches,
muscle aches and extreme tiredness.
These symptoms can also be caused
by other infections. True influenza
infection only occurs during annual
outbreaks
(epidemics)
when
flu
viruses are spreading in the local
community.
Outside
epidemic
periods,
flu-like
symptoms are usually caused by a
different type of illness.
_Tamiflu is not a flu vaccine _
Tamiflu is not a vaccine: it treats
infection, or prevents the flu virus
spreading. A vaccine gives you
antibodies against the virus. Tamiflu
will not change the effectiveness of
a
flu
vaccine,
and
you
might
be
prescribed both by your doctor.
BEFORE YOU USE TAMIFLU
-
_When you must not take it _
_ _
Do not take or receive Tamiflu if:

YOU ARE ALLERGIC
(
_hypersensitive_
)
to oseltamivir or any of the other
ingredients of
Tamiflu.
TALK

Termékjellemzők

PACK INSERT FOR MALAYSIA
T a m iflu
®
Oseltamivir phosphate 1. DESCRIPTION 1.1 Therapeutic/Pharmacologic Class of Drug Tamiflu is an antiviral agent 1.2 Type of Dosage Form Capsule, hard. 30 mg capsule consisting of a light yellow opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “30 mg”. Imprints are blue. The content of the capsule appear as a white powder . 45 mg capsule consisting of a grey opaque body bearing the imprint “ROCHE” and a grey opaque cap bearing the imprint “45 mg”. Imprints are blue. The content of the capsule appear as a white powder . 75 mg capsule consisting of a grey opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “75 mg”. Imprints are blue. The content of the app ear as a white powder . 1.3 Route of Administration Oral 1.4 Qualitative and Quantitative Composition Active ingredient: oseltamivir phosphate 30 mg capsules, containing 39.4 mg oseltamivir phosphate equivalent to 30 mg of oseltamivir. 45 mg capsules, containing 59 .1 mg oseltamivir phosphate equivalent to 45 mg of oseltamivir. 75 mg capsules, containing 98.5 mg oseltamivir phosphate equivalent to 75 mg of oseltamivir. 2. CLINICAL PARTICULARS 2.1 Therapeutic Indications Treatment of influenza Tamiflu is indicated for the treatment of influenza in children 6 to 12 months of age during a pandemic influenza outbreak . Tamiflu is indicated for the treatment of influenza in adults and children ≥1 year of age (see sections 2.2.1 Special Dosage Instructions, 2.4 W arnings and Precautions and 3.3 Non clinical Safety). Treatment should commence as soon as possible but no later than forty -eight hours after the onset of the initial symptoms of infection. Prophylaxis of influenza Tamiflu is indicated for post exposure prophylaxis in adults and children ≥1 year following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. 2.2 Dosage and Administration Tamiflu may be taken with or w